(Q34092436)

31 July 2017

title

Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer (English)

1 reference

31 July 2017

1 reference

J S Ross

1

1 reference

31 July 2017

K Wang

2

1 reference

31 July 2017

O R Elkadi

3

1 reference

31 July 2017

A Tarasen

4

1 reference

31 July 2017

L Foulke

5

1 reference

31 July 2017

C E Sheehan

6

1 reference

31 July 2017

G A Otto

7

1 reference

31 July 2017

G Palmer

8

1 reference

31 July 2017

R Yelensky

9

1 reference

31 July 2017

D Lipson

10

1 reference

31 July 2017

J Chmielecki

11

1 reference

31 July 2017

S M Ali

12

1 reference

31 July 2017

J Elvin

13

1 reference

31 July 2017

D Morosini

14

1 reference

31 July 2017

V A Miller

15

1 reference

31 July 2017

P J Stephens

16

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2014

1 reference

Journal of Clinical Pathology

31 July 2017

published in

1 reference

31 July 2017

volume

67

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

772-776

1 reference

Afatinib: a review of its use in the treatment of advanced non-small cell lung cancer

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

EGFR inhibition in non-small cell lung cancer: current evidence and future directions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Targeted therapies in small cell lung cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Deconvoluting mTOR biology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

ATP-competitive inhibitors of mTOR: an update.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

The molecular pathogenesis of small cell lung cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Epidermal growth factor receptor mutations in small cell lung cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Small cell lung cancer: treatment review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4145440

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

5 July 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202447

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202447

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202447

Epidermal growth factor receptor mutations in small cell lung cancer: a brief report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202447

EGFR mutations in small-cell lung cancers in patients who have never smoked.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202447

Small Cell Lung Cancer: The New Biology

21 January 2018

1 reference

12 December 2020

Prognostic value of KIT expression in small cell lung cancer

1 reference

12 December 2020

Small-cell lung cancer

1 reference

12 December 2020

A genetic snapshot of small cell lung cancer

1 reference

12 December 2020

10.1136/JCLINPATH-2014-202447

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference